Over the past 2–3 decades since the initial reports on GBA and LRRK2 PD (4, 5), numerous clinical observations have highlighted differences in clinical manifestations compared to sporadic PD (sPD). The gene discussed is LRRK2; the disease is Platelet storage pool disease.